首页|期刊导航|中医药信息|补肾填精方对绝经后骨质疏松症肾精亏虚证患者的临床疗效及血清能量代谢标志物的影响

补肾填精方对绝经后骨质疏松症肾精亏虚证患者的临床疗效及血清能量代谢标志物的影响OA

Clinical Efficacy of Bushen Tianjing Formula in Patients of Postmenopausal Osteoporosis with Kidney Essence Deficiency Pattern and Its Impact on Serum Energy Metabolism

中文摘要英文摘要

目的 评价补肾填精方治疗绝经后骨质疏松症(PMOP)肾精亏虚证的临床疗效,并分析其对患者血清能量代谢标志物的影响.方法 采用随机、双盲、安慰剂对照试验设计,选择江苏省中西医结合医院130例PMOP肾精亏虚证患者,依据区组随机化法随机分为试验组和对照组,每组各65例.试验实施过程中,对照组失访2例,试验组脱落3例,最终对照组纳入63例、试验组纳入62例.两组均接受基础西药治疗(阿仑膦酸钠片+钙尔奇D片+骨化三醇软胶囊),试验组口服补肾填精方颗粒剂,对照组口服安慰剂颗粒剂,疗程12个月.分别于治疗前、治疗6个月和12个月检测腰椎骨密度(T值)、腰背痛视觉模拟量表(VAS)评分、生活质量量表(SF-36)评分、骨代谢标志物(PⅠNP、β-CTX)及血清能量代谢标志物(AMPK、PGC-1α、ATP)水平.结果 两组骨密度均有提高,但组间比较差异无统计学意义(P>0.05);与对照组比较,试验组在降低VAS评分、提高SF-36评分方面显著优于对照组(P<0.01);与对照组比较,试验组血清PⅠNP水平显著高于对照组(P<0.01),而两组β-CTX水平比较差异无统计学意义(P>0.05);与对照组比较,试验组能显著上调血清p-AMPK/AMPK比值、PGC-1α及ATP水平(P<0.01).相关性分析证实,能量代谢标志物的改善与临床疗效指标呈正相关性.结论 补肾填精方能有效缓解绝经后骨质疏松症肾精亏虚证患者疼痛,改善生活质量并促进骨形成,其作用机制可能与激活AMPK/PGC-1α信号通路、改善机体能量代谢状态有关.

Objective To evaluate the clinical efficacy of Bushen Tianjing Formula in treating postmenopausal osteoporosis(PMOP)with kidney essence deficiency pattern,and to investigate its effect on serum energy metabolism markers of patients.Methods A randomized,double-blind,placebo-controlled trial was conducted.A total of 130 patients of PMOP with kidney essence deficiency pattern who were admitted to Jiangsu Provincial Hospital of Integrated Traditional and Western Medicine were randomly assigned to an experimental group and a control group using block randomization design,with 65 cases in each group.During the trial,2 participants in the control group withdrew,and 3 in the treatment group discontinued.Consequently,63 and 62 participants in the control and treatment groups,respectively,were included in the final analysis.Both groups received basic Western medicine treatment(alendronate sodium tablets+Caltrate D tablets+calcitriol soft capsules).The experimental group additionally received Bushen Tianjing Formula granule,while the control group received a placebo granules.The treatment lasted for 12 months.Lumbar spine bone mineral density(T-score),visual analogue scale(VAS)score for back pain,36-Item Short Form Health Survey(SF-36)score,bone metabolism markers(PⅠNP and β-CTX),and serum levels of energy metabolism markers(AMPK,PGC-1α,and ATP)were measured at baseline,6 months,and 12 months of treatment.Results Bone mineral density increased in both groups,but the inter-group comparison showed no statistically significant difference(P>0.05).Compared to the control group,the treatment group showed a significantly greater reduction in VAS scores and a greater improvement in SF-36 scores(P<0.01).The experimental group showed significantly higher serum PⅠNP levels than the control group(P<0.01),while no statistically significant difference was found in β-CTX levels between the two groups(P>0.05).Compared to the control group,the experimental group significantly upregulated the serum p-AMPK/AMPK ratio,PGC-1α,and ATP levels(P<0.01).Correlation analysis confirmed that the improvement in these energy metabolism markers was positively correlated with the clinical efficacy indicators.Conclusion Bushen Tianjing Formula can effectively alleviate pain,improve quality of life,and promote bone formation in patients of PMOP with kidney essence deficiency pattern.Its mechanism of action may be related to the activation of the AMPK/PGC-1α signaling pathway and the improvement of the body's energy metabolism status.

陆洋;蒋继亮;席志鹏;康然;谢林;鲍路瑶

江苏省中西医结合医院,江苏 南京 210028江苏省中西医结合医院,江苏 南京 210028江苏省中西医结合医院,江苏 南京 210028江苏省中西医结合医院,江苏 南京 210028江苏省中西医结合医院,江苏 南京 210028江苏省人民医院,江苏 南京 210029

绝经后骨质疏松症肾精亏虚补肾填精方能量代谢AMPK随机对照试验

Postmenopausal osteoporosisKidney essence deficiencyBushen Tianjing FormulaEnergy metabolismAMPKRandomized controlled trial

《中医药信息》 2026 (6)

45-51,7

江苏省干部保健科研项目(BJ24021)江苏省疾控局科技计划项目(JSJK2026D00038)

10.19656/j.cnki.1002-2406.20260607

评论